Status quo of opioid agonist maintenance therapy in Germany;Zum Stand der Substitutionstherapie in Deutschland

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 53, Issue 4, 2010, Pages 332-339

  Fischer, M ^a   Reimer, J ^a   Schafer I ^a   Haasen, C ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Health care; Heroine; Maintenance therapy; Methadone; Opiate dependence

Indexed keywords

METHADONE; NARCOTIC ANALGESIC AGENT;

ARTICLE; CLINICAL PRACTICE; DRUG POTENTIATION; GERMANY; HUMAN; OPIATE ADDICTION;

ANALGESICS, OPIOID; GERMANY; HUMANS; METHADONE; OPIOID-RELATED DISORDERS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 77951224755     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-010-1030-2     Document Type: Article

References (39)

1. Yoast R, Williams M-A, Deitchman S-D, Champion H-C (2001) Report of the council on scientific affairs: methadone maintenance and needle-exchange programs to reduce the medical and public health consequences of drug abuse. J Addict Dis 20:15-40
2. Davstad I, Stenbacka M, Leifman A, Romelsjö A (2009) An 18-year follow-up of patients admitted to methadone treatment for the first time. J Addict Dis 28:39-52
3. Kerr T, Marsh D, Li K et al (2004) Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend 80:329-335
4. Ward J, Mattick R-P, Hall W (1998) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam
5. Ball J-C, Ross A (1991) The effectiveness of methadone maintenance treatment: patients, programs, services and outcome. Springer, New York
6. Uchtenhagen A (2000) Auswertung und Resultate therapeutischer Interventionen. In: Uchtenhagen A, Zieglgängsberger W (Hrsg) Suchtmedizin. Urban & Fischer, München, S 423-433
7. Bundesministerium für Gesundheit (2009) Drogen- und Suchtbericht Mai 2009. http://www.bmg.bund.de/
8. De Vries T-J, Shippenberg T-S (2002) Neural systems underlying opiate addiction. J Neurosci 22:3321-3325
9. Gerlach R (2005) Zur neueren Geschichte der Substitutionsbehandlung. In: Gerlach R, Ströver H (Hrsg) Vom Tabu zur Normalität. Lambertus, Freiburg, S 18-29
10. Haasen C, Reimer J, Karow A (2004) Substitution. In: Krausz M, Haasen C (Hrsg) Kompendium Sucht. Thieme, Stuttgart New York, S 83-84
11. Dole V-P, Nyswander M-E (1967) Heroin addiction - a metabolic disease. Arch Intern Med 120:19-24
12. Günthner A, Ullmann R (2003) Substitution mit Methadon/L-Polamidon. In: Krausz M, Haasen C, Naber D (Hrsg) Pharmakotherapie der Sucht. Karger, Freiburg, S 107-121
13. Leune J (2001) Zahlen, Fakten und Trends im Hilfesystem. In: Deutsche Hauptstelle Gegen Die Suchtgefahren (Hrsg) Jahrbuch Sucht 2002. Neuland, Geesthacht
14. Krausz M, Verthein U, Degkwitz P et al (1998) Maintenance treatment of opiate addicts in Germany with medications containing codeine - results of a follow-up study. Addiction 93:1161-1167
15. Lewis J-W (1985) Buprenorphine. Drug Alcohol Depend 15:363-372
16. Walsh S-L, Preston K-L, Stitzer M-L et al (1994) Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther 55:569-580
17. Rosen M-I, Wallace E-A, Mcmahon T-J et al (1994) Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. Drug Alcohol Depend 35:141-149
18. Vignau J, Brunelle E (1998) Differences between general practitioner- and addiction centre prescribed buprenorphine substitution therapy in France. Eur Addict Res 4:24-28
19. Fuchs W, Haasen C (2003) Substitution mit Buprenorphin. In: Krausz M, Haasen C, Naber D (Hrsg) Pharmakotherapie der Sucht. Karger, Freiburg, S 134-139
20. Soyka M, Fischer G, Ladewig D et al (2000) Empfehlungen zur Anwendung von Buprenorphin (SUBUTEX) in der Substitutionsbehandlung opioidabhängiger Patienten in der Schweiz, Österreich und Deutschland. Suchtmed 2:43-53
21. Stoller K-B, Bigelow G-E, Walsh S-L, Strain E-C (2001) Effects of Buprenorphine/Naloxone in opioid-dependent humans. Psychopharmacology 154:230-242
22. Barnett P-G, Zaric G-S, Brandeau M-L (2001) The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States. Addiction 96:1267-1278
23. Caplehorn J, Deeks J-J (2006) A critical appraisal of the Australian comparative trial of methadone and buprenorphine maintenance. Drug Alcohol Rev 25:157-160
24. Ling W, Wesson D-R, Charuvastra C, Klett C-J (1996) A controlled trial comparing buprenorphin and methadone maintenance in opioid dependence. Arch Gen Psychiatry 53:401-407
25. Cadman M, Bell J (1998) Doctors detected selfadministring opioids in New South Wales 1985-1994: characteristics and outcome. Med J Australia 169:419-421
26. European Monitoring Centre for Drugs and Drug Addiction Emcdda (2000) Reviewing current practice in drug-substitution treatment in the European Union. Insight (3)
27. Kraigher D, Jagsch R, Gombas W et al (2005) Use of slow-release oral morphine for the treatment of opiod dependence. Eur Addict Res 11:145-151
28. Winklbaur B, Jagsch R, Ebner N et al (2008) Quality of life in patients receiving opiod maintenance therapy. Eur Addict Res 14:99-105
29. Risser D, Hönigschnabl S, Stichenwirth M et al (2001) Mortality of opiate users in Vienna, Austria. Drug Alcohol Depend 64:251-256
30. Hartnoll R-L, Mitcheson M-C, Battersby A et al (1980) Evaluation of heroin maintenance in controlled trial. Arch Gen Psychiatry 37:877-884
31. Steffen T, Uchtenhagen A, Gutzwiller F et al (1999) Die heroingestützte Behandlung von Opiatabhängigen. Internist 40:651-656
32. Van Den Brink W, Hendriks V-M, Blanken P et al (2003) Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 327:310
33. Haasen C, Verthein U, Degkwitz P et al (2007) Heroin-assisted treatment for opioid dependence. Randomised controlled trial. Br J Psychiatry 191:55-62
34. Verthein U, Kuhn S, Haasen C (2008) Das bundesdeutsche Modellprojekt zur heroingestützten Behandlung Opiatabhängiger - eine multizentrische, randomisierte, kontrollierte Therapiestudie. http://www.heroinstudie.de/
35. Mattick R-P, Breen C, Kimber J et al (2009) Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev
36. Mattick R-P, Kimber J, Breen C, Davioli M (2008) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev
37. Schäfer A, Wittchen H-U, Backmund M et al (2009) Psychopathological changes and quality of life in hepatits C virus-infected, opioid-dependent patients during maintenance therapy. Addiction 104:630-640
38. Schulte B, Gansefort D, Stöver H, Reimer J (im Druck) Strukturelle Hemmnisse in der Substitution und infektiologischen Versorgung Opiatabhängiger. Suchttherapie 10:1-6
39. Wittchen H-U, Apelt S-M, Soyka M et al (2008) Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug Alcohol Depend 95:245-257